← Back to patent-cliff list
MEX-CD1
Tier C — Watch / tradeMEX-CD1
Centre Hospitalier Universitaire De Nimes
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：急性肾损伤, Sepsis
Regional status
US
-
EU
Phase II
2026-06-04
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of MEX-CD1?
Approved indications include: 急性肾损伤, Sepsis.
When does the MEX-CD1 patent expire?
No public expiry year is available for MEX-CD1 yet; this page updates once verified.
How do I get a quote for MEX-CD1 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29